Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all (678)

bruno villoutreix

Institut National de la Santé et de la Recherche Médicale (INSERM)

Paris, France

Field Chief Editor

Frontiers in Drug Discovery
vicky m avery

Griffith University

Nathan, Australia

Specialty Chief Editor

Anti-Cancer Drugs
paula gomes

University of Porto

Porto, Portugal

Specialty Chief Editor

Anti-Infective Agents
charles c hong

School of Medicine, University of Maryland

Baltimore, United States

Specialty Chief Editor

Cardiovascular and Hematologic Drugs

Frontiers in Drug Discovery

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

bruno villoutreix

vicky m avery

paula gomes

charles c hong

Articles

Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2

Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins

HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets

Identification of novel genetic variants, including PIM1 and LINC01491, with ICD-10 based diagnosis of pulmonary arterial hypertension in the UK Biobank cohort

Volumes

Research Topics

Drug Discovery for Metabolic Diseases in the AI Era

Accelerating Peptide-Based Drug Discovery With Artificial Intelligence

How Common Inflammatory Patterns May Define Groups of Diseases

Discover and Design: Emerging Targeted Protein Degradation (TPD) Approaches and Modalities for Cancer Treatment